U.S. Physical Therapy Stock Forecast, Price & News

U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions

Is U.S. Physical Therapy a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" U.S. Physical Therapy stock.
View analyst ratings for U.S. Physical Therapy or view top-rated stocks.

What stocks does MarketBeat like better than U.S. Physical Therapy?

Wall Street analysts have given U.S. Physical Therapy a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but U.S. Physical Therapy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is U.S. Physical Therapy's next earnings date?

U.S. Physical Therapy is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for U.S. Physical Therapy.

How can I listen to U.S. Physical Therapy's earnings call?

U.S. Physical Therapy will be holding an earnings conference call on Thursday, November 4th at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its quarterly earnings results on Thursday, August, 5th. The company reported $0.96 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.22. The business earned $126.93 million during the quarter, compared to the consensus estimate of $125.10 million. U.S. Physical Therapy had a net margin of 7.08% and a trailing twelve-month return on equity of 16.50%.
View U.S. Physical Therapy's earnings history.

How has U.S. Physical Therapy's stock price been impacted by Coronavirus?

U.S. Physical Therapy's stock was trading at $93.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, USPH shares have increased by 10.9% and is now trading at $103.34.
View which stocks have been most impacted by COVID-19.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Thursday, August 5th. Investors of record on Friday, August 20th will be paid a dividend of $0.38 per share on Friday, September 17th. This represents a $1.52 annualized dividend and a dividend yield of 1.47%. The ex-dividend date is Thursday, August 19th. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.35.
View U.S. Physical Therapy's dividend history.

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy pays an annual dividend of $1.52 per share and currently has a dividend yield of 1.46%. U.S. Physical Therapy has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of U.S. Physical Therapy is 50.84%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, U.S. Physical Therapy will have a dividend payout ratio of 45.24% next year. This indicates that U.S. Physical Therapy will be able to sustain or increase its dividend.
View U.S. Physical Therapy's dividend history.

What guidance has U.S. Physical Therapy issued on next quarter's earnings?

U.S. Physical Therapy updated its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share guidance of $3.050-$3.150 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.740. The company issued revenue guidance of -.

What price target have analysts set for USPH?

2 brokerages have issued 1-year price targets for U.S. Physical Therapy's stock. Their forecasts range from $135.00 to $139.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $137.00 in the next year. This suggests a possible upside of 32.6% from the stock's current price.
View analysts' price targets for U.S. Physical Therapy or view top-rated stocks among Wall Street analysts.

Who are U.S. Physical Therapy's key executives?

U.S. Physical Therapy's management team includes the following people:

• Christopher J. Reading, President, Chief Executive Officer & Director
• Graham Reeve, Chief Operating Officer-East Region
• Carey P. Hendrickson, Chief Financial Officer
• Chadd Pence, Vice President-Information Systems
• Jayne Fleck Pool, Chief Compliance Officer & VP-Clinical Services

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy CEO Chris Reading on Glassdoor.com. Chris Reading has an approval rating of 49% among U.S. Physical Therapy's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of U.S. Physical Therapy's key competitors?

Some companies that are related to U.S. Physical Therapy include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Tenet Healthcare (THC), Encompass Health (EHC), Petco Health and Wellness (WOOF), Acadia Healthcare (ACHC), Select Medical (SEM), The Ensign Group (ENSG), Community Health Systems (CYH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE) and Capital Senior Living (CSU).
View all of USPH's competitors.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

What is U.S. Physical Therapy's stock symbol?

U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by many different institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (3.40%), Copeland Capital Management LLC (2.45%), Scout Investments Inc. (0.72%), Conestoga Capital Advisors LLC (0.12%), Chatham Capital Group Inc. (0.09%) and State of Alaska Department of Revenue (0.07%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Kathleen A Gilmartin, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson.
View institutional ownership trends for U.S. Physical Therapy.

Which major investors are selling U.S. Physical Therapy stock?

USPH stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, and Scout Investments Inc.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Bernard A Harris, Jr, Christopher J Reading, Edward L Kuntz, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Lawrance W Mcafee, and Mark J Brookner.
View insider buying and selling activity for U.S. Physical Therapy or view top insider-selling stocks.

Which major investors are buying U.S. Physical Therapy stock?

USPH stock was acquired by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Boston Trust Walden Corp, Conestoga Capital Advisors LLC, Legacy Wealth Asset Management LLC, State of Alaska Department of Revenue, Louisiana State Employees Retirement System, Ellsworth Advisors LLC, and Chatham Capital Group Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman, Kathleen A Gilmartin, and Regg E Swanson.
View insider buying and selling activity for U.S. Physical Therapy or or view top insider-buying stocks.

How do I buy shares of U.S. Physical Therapy?

Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is U.S. Physical Therapy's stock price today?

One share of USPH stock can currently be purchased for approximately $103.34.

How much money does U.S. Physical Therapy make?

U.S. Physical Therapy has a market capitalization of $1.33 billion and generates $422.97 million in revenue each year. The company earns $35.19 million in net income (profit) each year or $2.99 on an earnings per share basis.

How many employees does U.S. Physical Therapy have?

U.S. Physical Therapy employs 3,590 workers across the globe.

What is U.S. Physical Therapy's official website?

The official website for U.S. Physical Therapy is www.usph.com.

Where are U.S. Physical Therapy's headquarters?

U.S. Physical Therapy is headquartered at 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042.

How can I contact U.S. Physical Therapy?

U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at (713) 297-7000 or via email at [email protected].